Trademark: TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
Mark Identification
TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
Proof of use for TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
We do not have any records of a proof of use for TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY at this moment.
Possible trademark infringements of TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
Basic Information about TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
- Serial Number
- 79089155
- Filing Date
- 14 Oct 2010
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY on the blockchain with WikiTrademarks.io.
- First use of TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- H
- International Code
- 042
- US Codes
- 100; 101
Who owns TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY?
Correspondent
- Bernard-Boyle Hélène
- 65, quai Georges Gorse
- F-92100 Boulogne-Billancourt
- FRANCE
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY